CDC Recommends Use of Novavax’s COVID-19 Shot for Adolescents

A sticker reading, "COVID-19/Coronavirus vaccine/Injection only" and a medical syringe in front of a displayed Novavax logo in a photo illustration taken on Oct. 31, 2020. Dado Ruvic/Illustration/Reuters

The Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc.’s COVID-19 vaccine for adolescents aged 12 through 17.

The recommendation follows the Food and Drug Administration’s (FDA) authorization for the vaccine for the age group last week.